Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Briganti

Showing results (21-30 of 1,747) with videos related to

Pageof 175
Sort By:
European Urology|August 18, 2020
Reply to Jonathan Aning, Paul McCoubrie, and Jon Oxley's Letter to the Editor re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733-41Giorgio Gandaglia, Francesco Montorsi, Alberto Briganti
Lancet (London, England)|October 20, 2025
Front-line durvalumab and BCG in the treatment of non-muscle-invasive bladder cancerAndrea Necchi, Alberto Briganti, Francesco Montorsi
The Journal of Urology|March 8, 2021
The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer. LetterFrancesco Montorsi, Giorgio Gandaglia, Alberto Briganti
Current Opinion in Urology|August 11, 2018
Nomograms in urologic oncology, advantages and disadvantagesMarco Bandini, Nicola Fossati, Alberto Briganti
European Urology|February 29, 2016
Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30Pierre Blanchard, Alberto Briganti, Alberto Bossi
European Urology Focus|October 23, 2021
Evidence-based Urology: Surrogate Endpoints - ForAlberto Martini, Giorgio Gandaglia, Alberto Briganti
European Urology|August 18, 2020
Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27Francesco Montorsi, Andrea Salonia, Alberto Briganti
Cell Reports. Medicine|December 18, 2024
Reflections on the AMBASSADOR trial: The role of adjuvant pembrolizumab in muscle-invasive urothelial carcinomaPietro Scilipoti, Marco Moschini, Alberto Briganti
European Urology Focus|March 20, 2025
Same-day Outpatient Robotic Surgery in UrologyAntony Pellegrino, Alberto Briganti, Simone Crivellaro
European Urology|August 12, 2019
Re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review And Meta-analysis. Eur Urol 2019;76:284-303Francesco Montorsi, Giorgio Gandaglia, Alberto Briganti
Pageof 175

Showing results (21-30 of 1,747) with videos related to

Sort By:
Pageof 175
European Urology|August 18, 2020
Reply to Jonathan Aning, Paul McCoubrie, and Jon Oxley's Letter to the Editor re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733-41Giorgio Gandaglia, Francesco Montorsi, Alberto Briganti
Lancet (London, England)|October 20, 2025
Front-line durvalumab and BCG in the treatment of non-muscle-invasive bladder cancerAndrea Necchi, Alberto Briganti, Francesco Montorsi
The Journal of Urology|March 8, 2021
The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer. LetterFrancesco Montorsi, Giorgio Gandaglia, Alberto Briganti
Current Opinion in Urology|August 11, 2018
Nomograms in urologic oncology, advantages and disadvantagesMarco Bandini, Nicola Fossati, Alberto Briganti
European Urology|February 29, 2016
Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30Pierre Blanchard, Alberto Briganti, Alberto Bossi
European Urology Focus|October 23, 2021
Evidence-based Urology: Surrogate Endpoints - ForAlberto Martini, Giorgio Gandaglia, Alberto Briganti
European Urology|August 18, 2020
Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27Francesco Montorsi, Andrea Salonia, Alberto Briganti
Cell Reports. Medicine|December 18, 2024
Reflections on the AMBASSADOR trial: The role of adjuvant pembrolizumab in muscle-invasive urothelial carcinomaPietro Scilipoti, Marco Moschini, Alberto Briganti
European Urology Focus|March 20, 2025
Same-day Outpatient Robotic Surgery in UrologyAntony Pellegrino, Alberto Briganti, Simone Crivellaro
European Urology|August 12, 2019
Re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review And Meta-analysis. Eur Urol 2019;76:284-303Francesco Montorsi, Giorgio Gandaglia, Alberto Briganti
Pageof 175